Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_assertion type Assertion NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_head.
- NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_assertion description "[The safety and efficacy of targeting B7-H3 with a monoclonal antibody for the treatment of advanced-stage central nervous system cancer in children has been proven, making B7-H3 an attractive therapeutic target for this kind of tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_provenance.
- NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_assertion evidence source_evidence_literature NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_provenance.
- NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_assertion SIO_000772 24013874 NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_provenance.
- NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_assertion wasDerivedFrom befree-2016 NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_provenance.
- NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_assertion wasGeneratedBy ECO_0000203 NP1108462.RAu3jCY3p-BxdHq_WIEBY2GHX8Uqe44k7TU4XS9oAvQfs130_provenance.